Rosario P. M.
- Country
- Spain
- Department
- Servicio de Infecciosas, Microbiología Clínica y Medicina Preventiva
Research Overview
- Efficacy and Safety of Islatravir and Ulonivirine Once Weekly versus Bictegravir, Emtricitabine, and Tenofovir Alafenamide Once Daily in Treatment-Naïve Adults with HIV-1
- Lenacapavir with Teropavimab and Zinlirvimab (twice‑yearly) versus Cabotegravir/Rilpivirine in virologically suppressed adults with HIV‑1
- Evaluation of Dolutegravir/Lamivudine and Cabotegravir/Rilpivirine for Virologic Suppression in Antiretroviral-Naive HIV-1 Infected Adults
Data & Insights
Has run more than one trial at 57 of 123 partner sites.
Specializations
Infectious Diseases and Clinical Microbiology
Rosario Palacios Muñoz is involved in clinical research on HIV infection, chronic hepatitis C, chronic hepatitis B, hepatitis D, and resistant bacterial infections, with additional interest in severe infectious complications such as infective endocarditis and gram-negative infections.
- HIV and antiretroviral therapy
- Viral hepatitis
- Bacterial infections and endocarditis
- Monkeypox and emerging infections
Her work also extends to infectious disease prevention and the management of complex infections in hospital-based care.
Oncology and Hematologic Malignancies
Her clinical trial activity includes a broad range of solid and blood cancers, with a strong focus on breast cancer, lung cancer, prostate cancer, bladder cancer, and ovarian cancer, as well as lymphoma, leukemia, and myeloproliferative disorders.
- Breast cancer subtypes
- Non-small cell lung cancer and small cell lung cancer
- Prostate cancer and urothelial cancer
- Lymphoma, myeloma, and myelodysplastic syndromes
Her research also covers advanced solid tumors and biomarker-defined malignancies, reflecting engagement with precision oncology.
Cardiovascular Medicine and Metabolic Disease
Rosario Palacios Muñoz is active in studies of atherosclerotic cardiovascular disease, heart failure, atrial fibrillation, myocardial infarction, and hypertension, alongside metabolic conditions such as obesity, type 2 diabetes, and hypertriglyceridemia.
- Coronary artery disease and acute coronary syndromes
- Heart failure and cardiomyopathy
- Atrial fibrillation and stroke prevention
- Obesity, diabetes, and lipid disorders
Her portfolio includes research relevant to cardiovascular risk reduction and the treatment of cardiometabolic comorbidity.
Respiratory and Inflammatory Disorders
Her clinical interests include chronic obstructive pulmonary disease, asthma, idiopathic pulmonary fibrosis, and other progressive interstitial lung diseases, as well as immune-mediated conditions such as atopic dermatitis, hidradenitis suppurativa, and psoriasis.
- COPD and severe asthma
- Pulmonary fibrosis and interstitial lung disease
- Atopic and neutrophilic skin disease
- Inflammatory airway disease
She is also involved in trials addressing eosinophilic inflammation and chronic respiratory symptom control.
Liver Disease, Renal Disease, and Neurologic Conditions
Rosario Palacios Muñoz contributes to research in non-alcoholic steatohepatitis, primary biliary cholangitis, alpha-1 antitrypsin deficiency-associated liver disease, and hepatic encephalopathy, together with studies in chronic kidney disease, migraine, Tourette’s disorder, and multiple sclerosis.
- Metabolic liver disease
- Cholestatic and fibrotic liver disorders
- Kidney disease linked to diabetes and hypertension
- Neurologic and neuropsychiatric disorders
Her trial involvement spans chronic organ disease and selected neurologic conditions with unmet therapeutic need.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.